"A Deep Dive: The Breast Cancer Pill" - Pat Farnack
Research of a new breast cancer pill, Olaparib, found that it can be used to treat a certain rare form of breast cancer. Charles Shapiro, MD, director of cancer survivorship and translational breast cancer research at the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai said, ”the more we take a deep dive into the growth of these cells, the more we find that these breast cancers are different. Each woman has a unique breast cancer, instead of targeting that cancer with chemotherapy; we need to find the actual defect and targeting therapy based on the genes that make the tumor thick.” This breast cancer pill can be given to certain breast cancer populations instead of chemotherapy.
- Charles Shapiro, MD, Director, Cancer Survivorship, Translational Breast Cancer Research, The Tisch Cancer Institute, Professor, Medicine, Icahn School of Medicine at Mount Sinai